Joseph Romanelli is president, Human Health International for MSD. He has P&L responsibility for MSD’s 75-plus markets outside of the U.S. and leads a team of 14,000 colleagues.  

From 2021 to mid-2022, Joseph served as chief executive officer of JiXing Pharmaceuticals, a China-based biopharmaceutical company.

Prior to JiXing, Joseph served in a variety of strategic and operational roles with increasing responsibility at MSD and Schering-Plough for 25 years. He led MSD’s business in China from 2016 through 2021. During his tenure in China, MSD became the second largest multi-national pharmaceutical company by revenue in the market, as well as the second largest subsidiary for the company globally. Joseph’s previous roles at MSD include serving as chief of staff to the president of Human Health and managing the Human Health business for multiple markets in Asia Pacific. In addition, he led the Investor Relations team at MSD.

Joseph received his undergraduate degree from the University of Delaware and his master’s in Business Administration from Fordham University’s Gabelli School of Management.